Glycerol 3-phosphate



Compound IDCDAMM02072
Common nameGlycerol 3-phosphate
IUPAC name2,3-dihydroxypropyl dihydrogen phosphate
Molecular formulaC3H9O6P

Experimental data

Retention time12.72
Adduct[M+Na]+
Actual mz195.004
Theoretical mz195.003
Error2.47
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.5349

Identifiers and class information

Inchi keyAWUCVROLDVIAJX-GSVOUGTGSA-N
SmilesO=P(O)(O)OCC(O)CO
SuperclassLipids and lipid-like molecules
ClassGlycerophospholipids

Pharmacokinetic properties

Number of descriptor values(#stars)1
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)2
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)8
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)172.074
Computed dipole moment(dipole)7.982
Total solvent accessible surface area (SASA)372.96
Hydrophobic component of SASA (FOSA)96.386
Hydrophilic component of SASA (FISA)271.637
Pie component of the SASA (PISA)0
Weakly polar component of the SASA (WPSA)4.938
Total solvent accesible volume (volume)555.441
Number of hydrogen bond donors (donorHB)4
Number of hydrogen bond acceptors (accptHB)8.4
Free energy of solvation of dipole (dip^2/V)0.114706
Index of cohesive interaction in solids (ACxDN^.5/SA)0.045045
Globularity descriptor (glob)0.876182
Predicted polarizability in cubic angstroms (QPpolrz)10.938
Predicted hexadecane/gas partition coefficient (QPlogPC16)5.909
Predicted octanol/gas partition coefficient (QPlogPoct)15.192
Predicted water/gas partition coefficient (QPlogPw)14.834
Predicted octanol/water partition coefficient (QPlogPo/w)-1.203
Predicted aqueous solubility (QPlogS)-0.502
Conformation-independent predicted aqueous solubility (CIQPlogS)-0.403
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)0.079
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)1.687
Predicted brain/blood partition coefficient (QPlogBB)-2.266
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0.857
Predicted skin permeability, log Kp (QPlogKp)-5.758
PM3 calculated ionization potential (IP(ev))10.38
PM3 calculated electron affinity (EA(eV))-0.12
Number of likely metabolic reactions (#metab)2
Prediction of binding to human serum albumin (QPlogKhsa)-1.464
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)23.966
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)117.971
Number of nitrogen and oxygen atoms (#NandO)6
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
Q13526PIN1Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1T16308SEA
P52209PGD6-phosphogluconate dehydrogenaseT76497SEA
Q9HBW0LPAR2Lysophosphatidic acid receptor Edg-4T39380SEA
P43657LPAR6Lysophosphatidic acid receptor 6T13484SEA
Q9H1C0LPAR5Lysophosphatidic acid receptor 5T18616SEA
O95136S1PR2Sphingosine 1-phosphate receptor Edg-5T47888SEA
Q9UBY5LPAR3Lysophosphatidic acid receptor Edg-7T95923SEA
Q92633LPAR1Lysophosphatidic acid receptor Edg-2T92640SEA
Q99677LPAR4Lysophosphatidic acid receptor 4T58130SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16308DI0238Lung cancer[ICD-11: 2C25]Q13526PIN1
T76497DI0337Pituitary gland disorder[ICD-11: 5A60-5A61]P52209PGD
T47888DI0419Ulcerative colitis[ICD-11: DD71]O95136S1PR2
T95923DI0146Fibrosis[ICD-11: GA14-GC01]Q9UBY5LPAR3
T95923DI0399Systemic sclerosis[ICD-11: 4A42]Q9UBY5LPAR3
T92640DI0146Fibrosis[ICD-11: GA14-GC01]Q92633LPAR1
T92640DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]Q92633LPAR1
T92640DI0351Psoriasis[ICD-11: EA90]Q92633LPAR1
T92640DI0399Systemic sclerosis[ICD-11: 4A42]Q92633LPAR1

Copyright © 2025